Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Multicenter Observational Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With COPD Under Real-world Conditions

NCT07052396 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07052396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07052396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Multicenter Observational Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With COPD Under Real-world Conditions
Lead sponsor
Sanofi
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2025
Completion date
July 1, 2029
Enrollment
350 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)